Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs - an update.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 6
Abstract
Although neuroprotection is effective only against certain aspects of a complex cascade of pathological events during the development and course of epilepsy, it might be a promising option in the treatment of this disease. Some new data on the pathophysiology of epilepsy raised some hopes that the epileptogenesis process can be prevented. A question arises whether it is possible to make the epilepsy develop in a milder, easier to treat and non-progressive way without cognitive decline and drug-resistance. Moreover, once the epilepsy has already been triggered, there is as yet no conclusive evidence that the harmful effects of seizures on the brain can be reduced. So a great deal of further evaluation of antiepileptic drugs (AEDs) is required. Many similarities exist between cerebral ischemia and epilepsy regarding brain-damaging and autoprotective mechanisms that are activated following the injurious insult. Therefore, drugs that are effective in minimizing seizure-induced brain damage may also be useful in minimizing ischemic injury. Most AEDs have been tested in animal models of focal or global ischemia and some were already tested in humans for a possible neuroprotective effect. The existing data are rather scanty and insufficient but it appears that only drugs that have multiple mechanisms of action have some potential in conferring a degree of neuroprotection that could be clinically applicable to stroke patients. In this review, we focus on evidence of neuroprotective properties of novel and potential AEDs, based on animal experimental models of neurodegeneration. In conclusion, some of the newer AEDs show promise as possible neuroprotectants in epilepsy and acute ischemia but more studies are needed before clinical trials in humans could be undertaken.
Authors and Affiliations
Karolina Stępień, Michał Tomaszewski, Stanisław Czuczwar
Keywords
Related Articles
- EP ID EP133835
- DOI -
- Views 125
- Downloads 0
Impact of ursolic acid on chronic ethanol-induced oxidative stress in the rat heart.
Oxidative stress plays an important role as a mediator of myocardial damage produced by ethanol. This work was designed to investigate the effect of ursolic acid (UA), a reported radical scavenger and antioxidant, on oxi...
Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances.
The aim of this study was to compare the action of fenofibrate on monocyte cytokine release between patients with isolated mixed dyslipidemia and dyslipidemia coexisting with prediabetic states in relationship with its m...
Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioral and biochemical alterations in rats.
Aluminium, is a trace element available in the Earth's crust naturally and has a toxic potential for humans. It has been suggested as a contributing factor in the pathogenesis of Alzheimer's disease. β-Adrenoceptor block...
Effects of acetylsalicylic acid on the levels of sulfane sulfur and non-protein sulfhydryl groups in mouse tissues.
Background: The study is focused on searching for the link between acetylsalicylic acid (ASA) and sulfur metabolism. The present work aimed to investigate the effect of ASA on the level of the sulfane sulfur and non-prot...
Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus.
Olfactory bulbectomy (OB) is an established animal model of depression that has been investigated mostly in rats. As in human major depression, OB induces behavioral alterations that can be ameliorated by chronic antidep...